Abstract
Because the nonapeptide bradykinin can elicit some of the phenomena associated with an inflammatory response, considerable attention has been devoted for some time to the plasma protein pathway leading to the generation of this mediator. Although earlier studies were devoted chiefly to in vivo models or to crude plasma fractions, recent work has focused on the use of highly purified proteins to examine the sequence and nature of their interactions in this pathway. From these investigations have come better physicochemical characterization of the components of the kinin-forming system, the recognition that several of these components in themselves have biological activity compatible with an inflammatory response, further examination of modes of activating the kinin-forming sequence, and an increased understanding of the multiplicity of interactions of this sequence with other plasma systems implicated in inflammation. This chapter will discuss information in these areas, with a focus on studies using human material.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Amir, J., Ratnoff, O. D., and Pensky, J., 1972, Partial purification and some properties of a plasma inhibitor of activated plasma thromboplastin antecedent (factor XI), J. Lab. Clin. Med. 80:786.
Barlow, G. H., Summaria, L., and Robbins, K. C., 1969, Molecular weight studies on human plasminogen and plasmin at the microgram level, J. Biol. Chem. 244:1138.
Barnhart, M. I., Sulisz, L., and Bluhm, G. B., 1971, Role for fibrinogen and its derivatives in acute inflammation, in: Immunopathology of Inflammation (B. K. Forscher and J. C. Houck, eds.), pp. 59–65, Excerpta Medica, Amsterdam.
Becker, E. L., Mota, L, and Wong, D., 1968, Inhibition by antihistamines of the vascular permeability increase induced by bradykinin, Brit. J. Pharmacol. 34:330.
Beraldo, W. T., 1950, Formation of bradykinin in anaphylactic and peptone shock, Am. J. Physiol 163:283.
Blombäck, B., Blombäck, M., Edman, P., and Hessel, B., 1966, Human fibrinopeptides, isolation, characterization and structure, Biochim Biophys. Acta 115:371.
Boissonnas, R. A., Guttman, S., Jaquenoud, P. A., Konzett, H., and Stürmer, E., 1960, Synthesis and biological activity of peptides related to bradykinin, Experientia 16:326.
Bokisch, V. A., and Müller-Eberhard, H. J., 1970, Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase, J. Clin. Invest. 49:2427.
Burrowes, C. E., Movat, H. Z., and Soltay, M. J., 1971, The kinin system of human plasma. VI. The action of plasmin, Proc. Soc. Exp. Biol. Med. 138:959.
Chang, J., Freer, R., Stella, R., and Greenbaum, L. M., 1972, Studies on leukokinins. II. Studies on the formation, partial amino acid sequence and chemical properties of leukokinins M and PMN, Biochem. Pharmacol. 21:3095.
Cochrane, C. G., and Wuepper, K. D., 1971a, The kinin-forming system: Delineation and activation, in: VIth International Symposium of Immunopathology (P. A. Miescher, ed.), pp. 220–235, Benno-Schwabe, Basel.
Cochrane, C. G., and Wuepper, K. D., 1971b, The first component of the kinin-forming system in human and rabbit plasma: Its relationship to clotting factor XII (Hageman factor), J. Exp. Med. 134:986.
Cochrane, C. G., Revak, S. D., Aiken, B. S., and Wuepper, K. D., 1972a, The structural characteristics and activation of Hageman factor, in: Inflammation: Mechanisms and Control (I. H. Lepow and P. A. Ward, eds.), pp. 119–138, Academic Press, New York.
Cochrane, C. G., Sitzer, S. D., and Aiken, B. S., 1972b, Hageman factor, its structure and activation, Fed. Proc. 31:623 (abst.).
Cochrane, C. G., Wuepper, K. D., Aiken, B. S., Revak, S. D., and Spiegelberg, H. L., 1972c, The interaction of Hageman factor and immune complexes, J. Clin. Invest. 51:2736.
Cochrane, C. G., Revak, S. D., Wuepper, K. D., and Morrison, D., 1973, The structural characteristics of Hageman factor, in: VIIth International Symposium of Immunopathology (abst.).
Colman, R. W., Mattier, L., and Sherry, S., 1969, Studies on the prekallikrein (Kallikreinogen)-kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikrein, J. Clin. Invest. 48:11.
Davies, G. E., and Lowe, J. S., 1962, Further studies on a permeability factor released from guinea pig serum by antigen-antibody precipitates: Relationship to serum complement, Int. Arch. Allergy Appl. Immunol. 20:235.
Deutsch, D. G., and Mertz, E. T., 1970, Plasminogen: Purification from human plasma by affinity chromatography, Science 170:1095.
Diniz, C. R., and Carvalho, I. F., 1963, A micromethod for determination of bradykinino-gen under several conditions, Ann. N. Y. Acad. Sci. 104:77.
Eisen, V., and Smith, H. G., 1970, Plasma kinin formation by complexes of gamma globulin and serum proteins, Brit. J. Exp. Pathol. 51:328.
Elliott, D. F., Lewis, G. P., and Horton, E. W., 1960, The structure of bradykinin-A plasma kinin from ox blood, Biochem. Biophys. Res. Commun. 3:87.
Engel, S. L., Schaeffer, T. R., Gold, B. I., and Rubin, B., 1972, Inhibition of pressor effects of angiotensin I and augmentation of depressor effects of bradykinin by synthetic peptides, Proc. Soc. Exp. Biol. Med. 140:240.
Engelman, E. G., and Greenbaum, L. M., 1971, Kinin-forming activity of human lymphocytes, Biochem. Pharmacol. 20:922.
Epstein, W. V., Tan, M., and Melmon, K. L., 1969, Rheumatoid factor and kinin generation, Ann. N.Y. Acad. Sci. 168:173.
Erdös, E. G., 1966, Hypotensive peptides: bradykinin, kallidin and eledoisin, Advan. Pharmacol 4:1–90.
Erdös, E. G. (ed.), 1970, Handbook of Experimental Pharmacology, Vol. XXV, Springer-Verlag, Berlin.
Erdös, E. G., and Sloane, E. M., 1962, An enzyme in human blood plasma that inactivates bradykinin and kallidins, Biochem. Pharmacol. 11:585.
Erdös, E. G., and Yang, H. Y. T., 1970, Kininases, in: Handbook of Experimental Pharmacology, Vol. XXV (E. G. Erdös, ed.), pp. 289–323, Springer-Verlag, Berlin.
Forbes, C. B., Pensky, J., and Ratnoff, O. D., 1970, Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified C1 inactivator, J. Lab. Clin. Med. 76:809.
Freer, R., Chang, J., and Greenbaum, L. M., 1972, Studies on leukokinins. III. Pharmacological activities of leukokinins M and PMN, Biochem. Pharmacol. 21:3107.
Fritz, H., Wunderer, G., Kummer, K., Heimburger, N., and Werle, E., 1972, a1-Antitrypsin und C1¯ Inaktivator: Progressiv-inhibitoren für Serumkallikreine von Mensch und Schwein, Z. Physiol. Chem. 353:906.
Gigli, I., Ruddy, S., and Austen, K. F., 1968, The stoichiometric measurement of the serum inhibitor of the first component of complement by the inhibition of immune hemolysis, J. Immunol. 100:1154.
Gigli, I., Mason, J. W., Colman, R. W., and Austen, K. F., 1970, Interaction of plasma kallikrein with the C1¯ inhibitor, J. Immunol. 104:574.
Goetzel, E. J., and Austen, K. F., 1974, Active site chemotactic factors and the regulation of the human neutrophil chemotactic response, in: Chemotaxis: Its Biology and Biochemistry (E. Sorkin, ed.), in press, Karger, Basel.
Goodfriend, T. L., and Ball, D. B., 1969, Radioimmunoassay of bradykinin: Chemical modification to enable use of radioactive iodine, J. Lab. Clin. Med. 73:501.
Graham, R. C., Jr., Ebert, R. H., Ratnoff, O. D., and Moses, J. M., 1965, Pathogenesis of inflammation. II. In vivo observations of the inflammatory effects of activated Hageman factor and bradykinin, J. Exp. Med. 121:807.
Greenbaum, L. M., 1972, Leukocyte kininogenases and leukokinins from normal and malignant cells, Am. J. Pathol. 68:613.
Greenbaum, L. M., and Kim, K. S., 1967, The kinin-forming and kininase activities of rabbit polymorphonuclear leukocytes, Brit. J. Pharmacol. Chemother. 29:238.
Greenbaum, L. M., and Nagasawa, S., 1971, Substrates other than bradykininogen which release kinins in the presence of white cell enzymes, Pharmacologist 13:214 (abst.).
Greenbaum, L. M., and Yamafuji, K., 1966, The role of cathepsins in the inactivation of plasma kinins, in: Hypotensive Peptides (E. G. Erdös, N. Back, and F. Sicuteri, eds.), pp. 252–262, Springer-Verlag, Berlin.
Greenbaum, L. M., Freer, R., Chang, J., Semente, G., and Yamafuji, K., 1969, PMN-kinin and kinin metabolizing enzymes in normal and malignant leukocytes, Brit. J. Pharmacol 36:623.
Greenbaum, L. M., Semente, G. R., and Prakash, A., 1972, Studies on leukokininogen in human plasma, Fed. Proc. 31:534 (abst.).
Habal, R. M., and Movat, H. Z., 1972, Kininogens of human plasma, Res. Commun. Chem. Pathol. Pharmacol. 4:477.
Habermann, E., 1970, Kininogens, in: Handbook of Experimental Pharmacology, Vol. XXV (E. G. Erdös, ed.), pp. 250–288, Springer-Verlag, Berlin.
Harpel, P. C., 1970, Human plasma alpha 2-macroglobulin, an inhibitor of plasma kallikrein, J. Exp. Med. 132:329.
Harpel, P. C., 1971, Separation of plasma thromboplastin antecedent from kallikrein by the plasma α2-macroglobulin, kallikrein inhibitor, J. Clin. Invest. 50:2084.
Hathaway, W. E., Beihasen, L. P., and Hathaway, H. S., 1965, Evidence for a new plasma thromboplastin factor. I. Case report, coagulation studies and physicochemical properties, Blood 26:521.
Jackson, C. B., 1972, Characterization of two glycoprotein variants of bovine factor X and demonstration that the factor X zymogen contains two polypeptide chains, Biochemistry 11:4873.
Jacobsen, S., 1966, Substrates for plasma kinin-forming enzymes in human, dog, and rabbit plasmas, Brit. J. Pharmacol. 26:403.
Jacobsen, S., and Kriz, M., 1967, Some data on two purified kininogens from human plasma, Brit. J. Pharmacol. Chemother. 29:25.
Johnson, A. R., and Erdös, E. G., 1973, Release of histamine from mast cells by vasoactive peptides, Proc. Soc. Exp. Biol. Med. 142:1252.
Johnston, A. R., Cochrane, C. G., and Revak, S. D., 1974, The relationship between PF/dil and activated human Hageman factor, J. Immunol. 113:103.
Kagan, L. J., 1964, Some biochemical and physical properties of the human permeability globulins, Brit. J. Exp. Pathol. 45:604.
Kagan, L. J., Leddy, J. P., and Becker, E. L., 1963, The presence of two permeability globulins in human serum, J. Clin. Invest. 42:1353.
Kaplan, A. P., and Austen, K. F., 1970, A prealbumin activator of prekallikrein, J. Immunol. 105:802.
Kaplan, A. P., and Austen, K. F., 1971, A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin, J. Exp. Med. 133:696.
Kaplan, A. P., and Austen, K. F., 1972, The fibrinolytic pathway of human plasma: Isolation and characterization of the plasminogen pro activator, J. Exp. Med. 136:1378.
Kaplan, A. P., Spragg, J., and Austen, K. F., 1971, The bradykinin-forming system of man, in: Second International Symposium on the Biochemistry of the Acute Allergic Reactions (K. F. Austen and E. L. Becker, eds.), pp. 279–298, Blackwell, Oxford.
Kaplan, A. P., Kay, A. B., and Austen, K. F., 1972, A prealbumin activator of prekallikrein. III. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein, J. Exp. Med. 135:81.
Kaplan, A. P., Goetzl, E. J., and Austen, K. F., 1973, The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator, J. Clin. Invest. 52:2591.
Kay, A. B., Pepper, D. S., and Ewart, M. R., 1973, Generation of chemotactic activity for leukocytes by the action of thrombin on human fibrinogen, Nature New Biol. 243:56.
Kellermeyer, R. W., and Breckenridge, R. T., 1965, The inflammatory process in acute gouty arthritis. I. Activation of Hageman factor by sodium urate crystals, J. Lab. Clin. Med. 65:307.
Komiya, M., Kata, H., and Suzuki, T., 1972, Homology between bovine high molecular weight and low molecular weight kininogens, Biochem. Biophys. Res. Commun. 49:1438.
Lewis, G. P., 1958, Formation of plasma kinins by plasmin, J. Physiol. (Lond.) 140:285.
MacKay, M. W., Mues, A. A., Schachter, M., and Wilhelm, D. L., 1953, Susceptibility of the guinea pig to pharmacological factors from its own serum, Nature (Lond.) 172:714.
Magoon, E. H., Spragg, J., and Austen, K. J., 1974a, Human Hageman factor dependent pathways, in Advances in Biosciences, vol. 12 (G.Raspé, ed.), pp. 225–236, Pergamon Press Vieweg,Braunschwe
Magoon, E. H., Austen, K. F., and Spragg, J., 1914b, Immunoelectrophoretic analysis and radial immunodiffusion using plasminogen purified from fresh human plasma, Clin. Exp. Immunol. 17:345.
Marder, V. J., and Shulman, N. R., 1969, High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity, J. Biol. Chem. 244:2120.
Mashford, M. L., and Roberts, M. L., 1972, Determination of blood kinin levels by radioimmunoassay, Biochem. Pharmacol 21:2727.
Mason, B., and Miles, A. A., 1962, Globulin permeability factors without kininogenase activity, Nature (Lond.) 196:587.
McConnell, D. J., 1972, Inhibitors of kallikrein in human plasma, J. Clin. Invest. 51:1611.
Melmon K. L. and Cline M. J. 1968 The interaction of leukocytes and the kinin system Biochem. Pharmacol. Suppl.: 271.
Merrifield, R. B., 1964, Solid phase peptide synthesis. III. An improved synthesis of bradykinin, Biochemistry 3:1385.
Morell, A. G., Gregoriadis, G., Scheinberg, I. H., Hickman, J., and Ashwell, G., 1971, The role of sialic acid in determining the survival of glycoproteins in the circulation, J. Biol. Chem. 246:1461.
Moskowitz, R. W., Schwartz, H. J., Michel, B., Ratnoff, O. D., and Astrup, T., 1970, Generation of kinin-like agents by chondroitin sulfate, heparin, chitin sulfate, and human articular cartilage: Possible pathophysiologic implications, J. Lab. Clin. Med. 76:790.
Movat, H. Z., and DiLorenzo, N. L., 1968, Activation of the plasma kinin system by antigen-antibody aggregates. I. Generation of permeability factor in guinea pig serum, Lab. Invest. 19:187.
Movat, H. Z., DiLorenzo, N. L., and Treloar, M. D., 1968, Activation of the plasma kinin system by antigen-antibody aggregates. II. Isolation of permeability-enhancing and kinin releasing fractions from activated guinea pig serum, Lab. Invest. 19:201.
Movat, H. Z., Poon, M. C., and Takeuchi, Y., 1971, The kinin system of human plasma. I. Isolation of a low molecular weight activator of prekallikrein, Int. Arch. Allergy Appl. Immunol. 40:89.
Niewiarowski, S., Bankowski, E., and Rogowicka, I., 1965, Studies in the adsorption and activation of the Hageman factor (factor XII) by collagen and elastin, Thromb. Diath. Haemorrh. 14:387.
Norman, P. S., and Hill, B. M., 1958, Studies of the plasma system. III. Physical properties of the two plasmin inhibitors in plasma, J. Exp. Med. 108:639.
Ogston, D., Ogston, C. M., Ratnoff, O. D., and Forbes, C. D., 1969, Studies on a complex mechanism for the activation of plasminogen by kaolin and by chloroform: The participation of Hageman factor and additional cofactors, J. Clin. Invest. 48:1786.
Ogston, D., Bennett, N. B., Ogston, C. M., and Ratnoff, O. D., 1971, The assay of a plasma component necessary for the generation of a plasminogen activator in the presence of Hageman factor (Hageman factor co-factor), Brit. J. Haematol. 20:209.
Osbahr, A. J., Jr., Gladner, J. A., and Laki, K., 1963, The action of human thrombin on human fibrinogen, Biochem. Biophys. Res. Commun. 13:462.
Osbahr, A. J., Gladner, J. A., and Laki, K., 1964, Studies on the physiological activity of the peptide released during the fibrinogen—fibrin conversion, Biochim. Biophys. Acta 86:535.
Özge-Anwar, H., Ayse, H., Movat, H. Z., and Scott, J. G., 1972, The kinin system of human plasma. IV. The interrelationship between the contact phase of blood coagulation and the plasma kinin system in man, Thromb. Diath. Haemorrh. 27:141.
Pierce, J. V., 1968, Structural features of plasma kinins and kininogens, Fed. Proc. 27:52.
Pierce, J. V., and Webster, M. E., 1966, The purification and some properties of two different kallidinogens from human plasma, in: Hypotensive Peptides (E. G. Erdös, N. Back, and F. Sicuteri, eds.), pp. 130–138, Springer-Verlag, New York.
Rabiner, S. F., Goldfine, I. D., Hart, A., Summaria, L., and Robbins, K. C., 1968, Radioimmunoassay of human plasminogen and plasmin, J. Lab. Clin. Med. 74:216.
Ratnoff, O. D., 1965, Increased vascular permeability induced by human plasmin, J. Exp. Med. 122:905.
Ratnoff, O. D., 1972, Studies on the product of the reaction between activated Hageman factor (factor XII) and plasma thromboplastin antecedent (factor XI), J. Lab. Clin. Med. 80:704.
Ratnoff, O. D., and Miles, A. A., 1964, The induction of permeability-increasing activity in human plasma by activated Hageman factor, Brit. J. Exp. Pathol. 45:328.
Ratnoff, O. D., and Naff, G. B., 1967, The conversion of C’1s to C’1 esterase by plasmin and trypsin, J. Exp. Med. 125:337.
Ratnoff, O. D., Davie, E. W., and Mallett, D. L., 1961, Studies on the action of Hageman factor: Evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent, J. Clin. Invest. 40:803.
Ratnoff, O. D., Busse, R. J., Jr., and Sheon, R. P., 1968, The demise of John Hageman, New Engl. J. Med. 279:760.
Ratnoff, O. D., Pensky, J., Ogston, D., and Naff, G. B., 1969, The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C1r subcomponent of the first component of complement by serum C’1 esterase inhibitor, J. Exp. Med. 129:315.
Revak, S. D., Cochrane, C. G., and Johnston, A. R., 1973, Structure of Hageman factor in its native and activated forms, Fed. Proc. 32:845 (abst.).
Righetti, P. G., and Drysdale, J. W., 1971, Isoelectric focusing in Polyacrylamide gels, Biochim. Biophys. Acta 236:17.
Rinderknecht, H., Haverback, B. J., and Aladjem, F., 1967, Radioimmunoassay of brady-kinin, Nature (Lond.) 213:1130.
Robbins, K. C., and Summaria, L., 1966, An immunochemical study of human plasminogen and plasmin, Immunochemistry 3:29.
Robbins, K. C., Summaria, L., Elwyn, D., and Barlow, G. H., 1965, Further studies on the purification and characterization of human plasminogen and plasmin, J. Biol. Chem. 240:541.
Rochae Silva, M., 1970, Kinin Hormones, with Special References to Bradykinin and Related Kinins, Charles C Thomas, Springfield, Ill.
Schmid, K., 1968, Isolation, characterization and polymorphism of glycoproteins, in: Biochemistry of Glycoproteins and Related Substances, Part II: Cystic Fibrosis (E. Rossi and E. Stoll, eds.), pp. 4–58, Karger, Basel.
Schreiber, A. D., Kaplan, A. P., and Austen, K. F., 1913a, Inhibition by C1INH of Hageman factor fragment activation of coagulation, fibrinolysis, and kinin-generation, J. Clin. Invest. 52:1402.
Schreiber, A. D., Kaplan, A. P., and Austen, K. F., 1913b, Plasma inhibitors of the components of the fibrinolytic pathway in man, J. Clin. Invest. 52:1394.
Schwab, J., 1962, Kininases in leukocytes and other tissues, Nature (Lond.) 195:345.
Seidel, H., Stücker, H. U., and Vogt, W., 1969, The role of plasmin for kinin-formation in human plasma, Naunyn-Schmiedebergs Arch. Pharmakol. 264:305 (abst.).
Seidel, G., Stücker, H. U., and Vogt, W., 1971, Significance of direct and indirect kinin formation by plasmin in human plasma, Biochem. Pharmacol. 20:1859.
Soltay, M. J., Movat, H. Z., and Özge-Anwar, A. H., 1971, The kinin system of human plasma. V. The probable derivation of prekallikrein activator from activated Hageman factor, Proc. Soc. Exp. Biol. Med. 138:952.
Spragg, J., and Austen, K. F., 1971, The preparation of human kininogen. II. Further characterization of purified human kininogen, J. Immunol. 107:1512.
Spragg, J., and Austen, K. F., 1974, The preparation of human kininogen. III. Enzymatic digestion and modification, Biochem. Pharmacol. 23:781.
Spragg, J., Haber, E., and Austen, K. F., 1970a, The preparation of human kininogen and the elicitation of antibody for use in a radial immunodiffusion assay, J. Immunol. 104:1348.
Spragg, J., Talamo, R. C., and Austen, K. F., 1970b, Immuno chemistry of bradykinin and immunologic activation of the kinin system, in: Handbook of Experimental Pharmacology, Vol. XXV (E. G. Erdös, ed.), Springer-Verlag, Berlin.
Spragg, J., Kaplan, A. P., and Austen, K. F., 1973, The use of isoelectric focusing to study components of the human plasma kinin-forming system, Ann. N.Y. Acad. Sci. 209:372.
Spragg, J., Talamo, R. C., Wintroub, B. U., Haber, E., and Austen, K. F., 1974, Immunoassay of bradykinin and kininogen, in: Methods in Immunology and Immunochemistry, Vol. V (C. A. Williams and M. W. Chase, eds.), in press, Academic Press, New York.
Stecher, V. J., and Sorkin, E., 1972, The chemotactic activity of fibrin lysis products, Int. Arch. Allergy 43:879.
Stewart, P. B., and Bliss, J. Q., 1957, The permeability-increasing factor in diluted human plasma, Brit. J. Exp. Pathol. 38:462.
Suzuki, T., Kato, H., and Komiya, M., 1973, Biochemical properties of kininogens in plasma, in: Proceedings of the Vth International Congress of Pharmacology, pp. 296–306, Karger, Basel.
Talamo, R. C., Spragg, J., Haber, E., and Austen, K. F., 1969, Radioimmunoassay for bradykinin with an iodinated bradykinin analog and dextran coated charcoal, in: Cellular and Humoral Mechanisms in Anaphylaxis and Allergy (H. Z. Movat, ed.), pp. 226–232, Karger, Basel.
Trautschold, I., 1970, Assay methods in the kinin system, in: Handbook of Experimental Pharmacology, Vol. XXV (E. G. Erdös, ed.), pp. 52–81, Springer-Verlag, Berlin.
Treloar, M. P., and Movat, H. Z., 1970, Isolation of two small molecular weight activators of the plasma kinin-system in the guinea pig, Fed. Proc. 29:576 (abst.).
Tucker, E. S., III, and Wuepper, K. D., 1969, Contact factor (CF) activation of rabbit kininogenase, Fed. Proc. 28:363 (abst.).
Ulevitch, R. J., and Letchford, D. J., 1973, A direct enzymatic assay of Hageman factor activity, Fed. Proc. 32:845 (abst.).
Vogt, W., 1964, Kinin formation by plasmin, an indirect process mediated by activation of kallikrein, J. Physiol (Lond.) 170:153.
Ward, P. A., 1967, A plasmin-split fragment of C’3 as a new chemotactic factor, J. Exp. Med. 126:189.
Webster, M., 1969, The kinin system-A review, in: Cellular and Humoral Mechanisms in Anaphylaxis and Allergy (H. Z. Movat, ed.), pp. 207–214, Karger, Basel.
Webster, M. E., 1972, The interaction of Hageman factor, prekallikrein activator and plasmin, in: Proceedings of the Vth International Congress of Pharmacology, p. 248 (abst.), Karger, Basel.
Webster, M. E., and Pierce, J. V., 1963, The nature of the kallidins released from human plasma by kallikreins and other enzymes, Ann. N. Y. Acad. Sci. 104:91.
Weiss, A. S., Gallin, J. I., and Kaplan, A. P., 1973, Fletcher factor deficiency: Abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation attributable to absence of prekallikrein, Fed. Proc. 32:845 (abst.).
Weiss, A. S., Gallin, J. I., and Kaplan, A. P., 1974, Fletcher factor deficiency: a diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity and kinin generation, J. Clin. Invest. 53:622.
Wilner, G. D., Nossel, H. L., and LeRoy, E. C., 1968, Activation of Hageman factor by collagen, J. Clin. Invest. 47:2608.
Wintroub, B. U., Spragg, J., Stechschulte, D. J., and Austen, K. F., 1973, Characterization of and immunoassays for components of the kinin-generating system in: Control Mechanisms in Reagin-Mediated Hypersensitivity (L. Goodfriend, A. Sehon, and R. P. Orange, eds.), pp. 495–512, Marcel Dekker, New York.
Wuepper, K. D., 1972, Biochemistry and biology of components of the plasma kinin-forming system, in: Inflammation: Mechanisms and Control (I. H. Lepow and P. A. Ward, eds.), pp. 93–117, Academic Press, New York.
Wuepper, K. D., and Cochrane, C. G., 1971, Isolation and mechanism of activation of components of the plasma kinin-forming system, in: Second International Symposium on the Biochemistry of the Acute Allergic Reactions (K. F. Austen and E. L. Becker, eds.), pp. 299–320, Blackwell, Oxford.
Wuepper, K. D., and Cochrane, C. G., 1972, Plasma prekallikrein: Isolation, characterization, and mechanism of activation, J. Exp. Med. 135:1.
Wuepper, K. D., Tucker, E., III, and Cochrane, C. G., 1970, Plasma kinin system: Proenzyme components, J. Immunol. 105:1307.
Yang, H. Y. T., and Erdös, E. G., 1967, Second kininase in human blood plasma, Nature (Lond.) 215:1402.
Yang, H. Y. T., Erdös, E. G., and Levin, Y., 1970, A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin, Biochim. Biophys. Acta 214:374.
Yang, H. Y. T., Erdös, E. G., and Levin, Y., 1971, Characterization of a dipeptide hydrolase (kininase II: angiotensin I converting enzyme), J. Pharmacol. Exp. Ther. 177:291.
Yonemasu, K., Stroud, R. M., Niedermeier, W., and Butler, W. T., 1971, Chemical studies on C1q: a modulation of immunoglobulin biology, Biochim. Biophys. Res. Commun. 43:1388.
Zachariae, H., Malmquist, J., and Oates, J. A., 1966, Kininase in human polymorphonuclear leukocytes, Life Sci. 5:2347.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Plenum Press, New York
About this chapter
Cite this chapter
Spragg, J. (1974). The Plasma Kinin-Forming System. In: Weissmann, G. (eds) Mediators of Inflammation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-0745-7_4
Download citation
DOI: https://doi.org/10.1007/978-1-4684-0745-7_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-0747-1
Online ISBN: 978-1-4684-0745-7
eBook Packages: Springer Book Archive